Edge Pharmasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-03-11
Share capital
5 000,00 PLN
Activity description

Edge Pharma is a pharmaceutical company that imports and distributes high-quality medical solutions, including Vitamin K2 and Coenzyme Q10. Founded in 2018, it operates in both China and Europe, focusing on production processes, sales networks, and providing services such as API sourcing, audits, and product development. The company aims to be a global supplier of affordable and innovative medicine and treatment solutions.

Registered address
ul. Kacza 9/16, 01-013 Warszawa, Poland
Website
edgepharma.euWebsite active
Email
Email address current
Phone
Social media

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 19.86kMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD -35.38kMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 36.03kMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 47.10kMedianUSD 539.29kAverageUSD 10.66m

Bank accounts

Registered as a VAT taxpayer on 2019-09-07. Active

  • mBank
    55 1140 2004 0000 3612 0903 6858
  • mBank
    81 1140 2004 0000 3502 7903 7299

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

1 tender recorded as contractor, with a total value of $165,462.

Publication dateSubjectAmountContracting authority
Mar 9, 2026
Dostawa surowca 5-Azido Oseltamivir
$165,462Sieć Badawcza Łukasiewicz - Instytut Chemii Przemysłowej Imienia Profesora Ignacego Mościckiego

Authorized Representatives

Grzegorz Marciniak — Management Board Member
Karol Maria Tyrała — Management Board Member

Manner of representation

In the case of a multi-member management board, each of the members of the management board acting independently is authorized to submit declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
Grzegorz Marciniak (43)
25$675.3150%
Karol Maria Tyrała (43)
25$675.3150%

Beneficial owners

PersonRights
Grzegorz Marciniak (43)
Shareholder of a limited liability company, 2500.0 PLN
Karol Maria Tyrała (43)
Shareholder of a limited liability company, 2500.0 PLN

Competitors

NameRevenueWebsite
Toto Pharma Polandsp. z o.o.$66,269.14totopharma.com
Leenlife PharmaS.A.$47,609.40leenlife.com
THC PharmaS.A.$39,093.70thc-pharma.pl
Apteczka Pacjentasp. z o.o.$30,042.28apteczkapacjenta.pl
Synergy Internationalsp. z o.o.$23,050.13synergyeurope.eu
Concept4you InternationalS.A.$14,404.04concept4you.pl
Kayom Tradesp. z o.o.$13,704.29kayomtrade.pl
Filicosp. z o.o.$11,710.75filico.eu
Polidental Tradesp. z o.o.$9,409.06poli.dental
Endolink PharmaS.A.$5,022.60endolink.pl

Change history

DateEvent
2026-09-02Address change (Ul. Marii Kazimiery 23k, 01-641, Warszawa → Ul. Kacza 9/16, 01-013, Warszawa)
2019-03-11Entered in the register

FAQ

Last updated: 2026-09-02